ConductScience.org, home

Library / Genes

ANXA1: annexin A1

1 protein, 281 patents, 0 drugs, 0 trials, 3,056 NIH grants and 7,204 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolANXA1HGNC
Nameannexin A1HGNC
NCBI Gene ID301NCBI Gene
HGNC IDHGNC:533HGNC
EnsemblENSG00000135046NCBI Gene
AliasesANX1, LPC1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P04083Annexin A13465Ensembl, GeneID, HGNCUniProt

Patents 281

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026507871 A2026-03-061P04083Espacenet
JP 2026004568 A2026-01-1437526P04083Espacenet
JP 2026004568 A2026-01-1437527P04083Espacenet
EP 4650780 A22025-11-191635P04083Espacenet
EP 4641201 A22025-10-291241P04083Espacenet
EP 4595950 A22025-08-061P04083Espacenet
JP 2025090566 A2025-06-176P04083Espacenet
JP 2025517969 A2025-06-121241P04083Espacenet
JP 2025517970 A2025-06-121635P04083Espacenet
JP 2025071106 A2025-05-021P04083Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3056

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant352,025NIH's project files
P30CA008748Cancer Center Support Grant142,025NIH's project files
ZIABC010301Development of Recombinant Toxins to Treat Hematologic Malignancies112,025NIH's project files
ZIAES090057Glucocorticoid Hormone Action82,025NIH's project files
P30CA016056Roswell Park Cancer Center Support Grant62,025NIH's project files
R01NS047726Mechanisms of resealing and rebuilding in muscle repair62,025NIH's project files
P30CA030199Cancer Center Support Grant (CCSG)52,025NIH's project files
P30CA068485Cancer Center Support Grant52,025NIH's project files
P30ES010126UNC Center for Environmental Health and Susceptibility52,025NIH's project files
R01AG011085Ubiquitin‐mediated proteolysis and cell cycle control52,025NIH's project files

Papers 7204

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42814136PubTator, text miningPubMed
42810630PubTator, text miningPubMed
42787327PubTator, text miningPubMed
42762187PubTator, text miningPubMed
42748406PubTator, text miningPubMed
42746022PubTator, text miningPubMed
42740575PubTator, text miningPubMed
42738308PubTator, text miningPubMed
42724846PubTator, text miningPubMed
42695008PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license